Form 4: Synopsys CFO Shelagh Glaser Acquires Stock Options and Restricted Stock Units
SEC Form 4
Synopsys CFO Shelagh Glaser was granted stock options and restricted stock units on December 18, 2024, according to a recent SEC filing.
Summary
- Shelagh Glaser, CFO of Synopsys Inc., received a grant of 8,876 non-qualified stock options with an exercise price of $494.43 on December 18, 2024.
- These options vest over time, with 25% becoming exercisable on December 18, 2025, and the remainder vesting in 12 equal quarterly installments.
- Glaser also received 3,034 restricted stock units (RSUs) on the same date.
- These RSUs vest with 25% vesting on December 8, 2025, and the remaining units vesting in three equal annual installments.
- Both the stock options and RSUs were granted under the Synopsys, Inc. 2006 Employee Equity Incentive Plan.
Sentiment
Score: 7
Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management interests with shareholders. There are no negative implications.
Positives
- The grant of stock options and RSUs aligns the CFO's interests with those of the shareholders.
- The vesting schedule encourages long-term commitment from the CFO.
Industry Context
This type of equity grant is a common practice in the technology industry to incentivize and retain key executives.
Comparison to Industry Standards
- Equity grants are a standard component of executive compensation packages in the tech industry, similar to companies like Cadence Design Systems and Mentor Graphics.
- The vesting schedules are typical, designed to encourage long-term performance and retention, aligning with industry norms.
Stakeholder Impact
- Shareholders may view this positively as it aligns the CFO's interests with the company's long-term performance.
- Employees may see this as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 12/18/2024 | Date of grant for stock options and restricted stock units. |
| 12/18/2025 | Date when 25% of the stock options become exercisable. |
| 12/08/2025 | Date when 25% of the restricted stock units vest. |
| 12/18/2031 | Expiration date of the stock options. |
| 12/08/2028 | Expiration date of the restricted stock units. |
| 12/20/2024 | Date the SEC Form 4 was signed. |
Keywords
Synopsys, Stock Options, Restricted Stock Units, SEC Form 4, Shelagh Glaser, CFO, Equity Incentive Plan, Vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.